Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Brenda Stofan"'
Autor:
Josée Bouchard, Rakesh Malhotra, Shamik Shah, Yu-Ting Kao, Florin Vaida, Akanksha Gupta, David T Berg, Brian W Grinnell, Brenda Stofan, Ashita J Tolwani, Ravindra L Mehta
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120770 (2015)
Endothelial dysfunction contributes to the development of acute kidney injury (AKI) in animal models of ischemia reperfusion injury and sepsis. There are limited data on markers of endothelial dysfunction in human AKI. We hypothesized that Protein C
Externí odkaz:
https://doaj.org/article/2b4eb4f10f4b4875bf54f11fc5e3fd60
Autor:
Ravindra L. Mehta, Florin Vaida, Brian W. Grinnell, Shamik H. Shah, Ashita Tolwani, Rakesh Malhotra, David T. Berg, Yu-ting Kao, Akanksha Gupta, Brenda Stofan, Josée Bouchard
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120770 (2015)
PloS one, vol 10, iss 3
PLoS ONE
PloS one, vol 10, iss 3
PLoS ONE
Endothelial dysfunction contributes to the development of acute kidney injury (AKI) in animal models of ischemia reperfusion injury and sepsis. There are limited data on markers of endothelial dysfunction in human AKI. We hypothesized that Protein C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f12dd032849933152b44b02d7063d30
http://europepmc.org/articles/PMC4366245?pdf=render
http://europepmc.org/articles/PMC4366245?pdf=render
Autor:
Robert A. Oster, Brenda Stofan, Keith M. Wille, Ashita Tolwani, Ruth C. Campbell, K. Robin Lai
Publikováno v:
Journal of the American Society of Nephrology : JASN. 19(6)
The effect of dosage of continuous venovenous hemodiafiltration (CVVHDF) on survival in patients with acute renal failure (ARF) is unknown. In this study, 200 critically ill patients with ARF were randomly assigned to receive CVVHDF with prefilter re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdfef211103c93298971ddfb06206e7e
https://pubmed.ncbi.nlm.nih.gov/18480309
https://pubmed.ncbi.nlm.nih.gov/18480309
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 1(1)
Obstacles to the widespread use of continuous renal replacement therapy (CRRT) include the need for anticoagulation, customized solutions, and complex protocols that carry an attendant risk for error, raise cost, and increase pharmacy and nursing wor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52add71bf9a11a8a84aaeba9811ef0ac
https://pubmed.ncbi.nlm.nih.gov/17699194
https://pubmed.ncbi.nlm.nih.gov/17699194